What pharmacists should know about drug diversion

Drug diversion is a pervasive issue that continues to challenge the healthcare industry. Baker Tilly participated in a panel discussion hosted by LogicStream Health, The hospital pharmacy leader and the fight against drug diversion, focused on how to improve identification of drug diversion in the investigation process.

After the panel discussion, Pharmacy Times published, What pharmacists should know about drug diversion, an article with insights from the panelists highlighting ways to better identify diversion activity and manage investigations.

For more information on this topic or to speak with a specialist, contact our team.